Sponsor Pipeline

Biotech Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
1
Recruiting
3
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 3
3
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06879691 A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous… Head and Neck Cancer Active, Not Recruiting
Phase 3
NCT05978050 Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric… Gastric or Esophagogastric Junction Adenocarcinoma Recruiting
NCT06333821 A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment… Cervical Cancer Not Yet Recruiting
NCT06343116 Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory… Refractory Metastatic Colorectal Cancer Not Yet Recruiting
Phase 1/2
NCT07510841 JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR Solid Cancers Not Yet Recruiting
Phase 1
NCT06633055 A Phase I Clinical Trial of JH013 Injection Healthy Subjects (HS) Not Yet Recruiting
NCT07413536 A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy… Health Adult Subjects Not Yet Recruiting
NCT07582822 JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC Advanced Solid Tumor Not Yet Recruiting
Disease Areas
Get alerts when Biotech Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free